<DOC>
	<DOCNO>NCT00743405</DOCNO>
	<brief_summary>This First Time Human Study ass safety , tolerability pharmacokinetics single dos GSK1034702 healthy subject . It single-blind , randomize , placebo-controlled , single oral dose , dose-rising , cross-over study healthy male female ( non-child bearing potential ) subject . Subjects randomize cohort 10 subject cohort recruit pre-defined safety PK stop limit reach . Each subject receive placebo 4 dos GSK1034702 randomize sequence 5 separate study occasion .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics GSK1034702 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Healthy determine responsible physician , base medical evaluation include familial medical history , physical examination , laboratory test cardiac monitoring . Male female 18 55 year age . A female subject eligible participate nonchildbearing potential Body weight &gt; 50 kg BMI within range 19 29.9 kg/m2 ( inclusive ) . Capable give write informed consent , include compliance requirement restriction list consent form . Capable reading , comprehend write English sufficient level complete studyrelated material . Demonstrates evidence mental impairment . No comorbid Psychiatric Disorders define use Mini International Neuropsychiatric Interview A positive prestudy drug/alcohol screen . A positive prestudy Hepatitis B , Hepatitis C HIV . History regular alcohol consumption . The subject participate clinical trial receive investigational product within following time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Exposure four new chemical entity within 12 month prior first dose day . Use prescription nonprescription drug , include vitamin , herbal dietary supplement . History sensitivity study medication , component thereof history drug allergy . Where participation study would result donation blood blood product excess 500 mL within 56 day period . Pregnant female , female plan pregnancy lactate female . Unwillingness inability follow procedure outline protocol . History sensitivity heparin heparininduced thrombocytopenia . Subjects current history psychiatric illness . Subjects history suicidal attempt behavior . Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product . Consumption red wine , seville orange , grapefruit grapefruit juice ( pummelo , exotic citrus fruit , grapefruit hybrid fruit juice ) 7 day prior first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>M1 receptor agonist</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>GSK1034702</keyword>
	<keyword>safety</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>